Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024
April 23, 2024
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, participated in the ISPE Europe Annual Conference held on 16-18 April 2024 in Lisbon. This Conference brings together pharmaceutical and biopharmaceutical professionals at all levels to discuss the industry’s most important topics.
During the conference dr. Polina Dombure had meetings with industry leaders, as well as current and prospective partners, for networking and knowledge exchange. The active participation of dr. Polina Dombure underscores Inpharmatis Group’s fostering collaborative partnerships and enhances its position in the EU and CIS pharmaceutical markets as a leader in GMP and regulatory fields.
For more information about Inpharmatis Group and its provided services, please contact us at info@inpharmatis.com.
Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024
Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024
Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024
Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024
Join us at RAPS Euro Convergence 2024 on 6-8 May in Berlin, Germany
April 26, 2024
Полина Домбуре, директор Inpharmatis, приняла участие в ISPE Europe Annual Conference 2024
April 23, 2024
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
April 23, 2024
Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024